Bausch & Lomb (BLCO) Receivables - Net (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Receivables - Net came in at $1.2 billion in Q2 2026, up 7.01% on a YoY basis from $1.1 billion in Q2 2025, and up 4.88% quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Receivables - Net (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Receivables - Net for 6 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Net rose 7.01% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (up 7.01% YoY), and the FY2025 full-year result was $1.2 billion, up 19.01% from the prior year.
- Receivables - Net advanced to $1.2 billion in Q2 2026 per BLCO's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $1.2 billion in Q4 2025 and bottomed at $674.0 million in Q2 2022.
- Historically, Receivables - Net has averaged $916.1 million across 5 years, with a median of $931.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net decreased 3.12% in 2023, then gained 28.85% in 2024.
- Over 5 years, Receivables - Net stood at $724.0 million in 2022, then grew by 15.88% to $839.0 million in 2023, then climbed by 22.29% to $1.0 billion in 2024, then rose by 19.01% to $1.2 billion in 2025, then decreased by 5.0% to $1.2 billion in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $1.2 billion, $1.1 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.22 Bn |
| Sep 30, 2025 | 1.09 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 943.00 Mn |
| Jun 30, 2024 | 986.00 Mn |
| Mar 31, 2024 | 920.00 Mn |
| Dec 31, 2023 | 839.00 Mn |
| Sep 30, 2023 | 783.00 Mn |
| Jun 30, 2023 | 791.00 Mn |
| Mar 31, 2023 | 714.00 Mn |
| Dec 31, 2022 | 724.00 Mn |
| Sep 30, 2022 | 685.00 Mn |
| Jun 30, 2022 | 674.00 Mn |
| Mar 31, 2022 | 737.00 Mn |
| Dec 31, 2021 | 721.00 Mn |